BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 18386202)

  • 1. How to manage conflicts of interest with industry?
    Schowalter JE
    Int Rev Psychiatry; 2008 Apr; 20(2):127-33. PubMed ID: 18386202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
    Kerridge I; Maguire J; Newby D; McNeill PM; Henry D; Hill S; Day R; Macdonald G; Stokes B; Henderson K
    Intern Med J; 2005 Apr; 35(4):206-10. PubMed ID: 15836497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.
    Schetky DH
    Child Adolesc Psychiatr Clin N Am; 2008 Jan; 17(1):113-25, ix-x. PubMed ID: 18036482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who pays the piper?
    Friedli L
    Ment Health Today; 2003 Nov; ():8-9. PubMed ID: 14689593
    [No Abstract]   [Full Text] [Related]  

  • 5. The long arm of financial conflicts of interest: extensions into lined pockets, research and review, and the United States Senate.
    Rivkees SA
    J Pediatr Endocrinol Metab; 2008 Jul; 21(7):607-9. PubMed ID: 18780592
    [No Abstract]   [Full Text] [Related]  

  • 6. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
    Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
    Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gifts to physicians from the pharmaceutical industry: an ethical analysis.
    Marco CA; Moskop JC; Solomon RC; Geiderman JM; Larkin GL
    Ann Emerg Med; 2006 Nov; 48(5):513-21. PubMed ID: 17052550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industry-sponsored research.
    Okike K; Kocher MS; Mehlman CT; Bhandari M
    Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychology in the prescription era: building a firewall between marketing and science.
    Antonuccio DO; Danton WG; McClanahan TM
    Am Psychol; 2003 Dec; 58(12):1028-43. PubMed ID: 14664691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
    Newcombe JP; Kerridge IH
    Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical industry agenda setting in mental health policies.
    Gosden R; Beder S
    Ethical Hum Sci Serv; 2001; 3(3):147-59. PubMed ID: 15278977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The accuracy of psychiatric medication advertisements in medical journals.
    Spielmans GI; Thielges SA; Dent AL; Greenberg RP
    J Nerv Ment Dis; 2008 Apr; 196(4):267-73. PubMed ID: 18414120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Big pharma and American psychiatry.
    Sharfstein SS
    J Nerv Ment Dis; 2008 Apr; 196(4):265-6. PubMed ID: 18414119
    [No Abstract]   [Full Text] [Related]  

  • 14. Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia.
    McNeill PM; Kerridge IH; Henry DA; Stokes B; Hill SR; Newby D; Macdonald GJ; Day RO; Maguire J; Henderson KM
    Intern Med J; 2006 Sep; 36(9):571-8. PubMed ID: 16911549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Debunking myths in physician-industry conflicts of interest.
    Lichter PR
    Am J Ophthalmol; 2008 Aug; 146(2):159-71. PubMed ID: 18538299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The corporate coauthor.
    Fugh-Berman A
    J Gen Intern Med; 2005 Jun; 20(6):546-8. PubMed ID: 15987332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between paediatricians and commerce.
    Hilliard T; Chambers T
    Paediatr Respir Rev; 2006 Mar; 7(1):54-9. PubMed ID: 16473818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship of psychiatrists to the pharmaceutical companies--part of, or the solution to, the problem].
    Insel TR
    Lege Artis Med; 2010 Sep; 20(9):630-1. PubMed ID: 21469310
    [No Abstract]   [Full Text] [Related]  

  • 19. Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States.
    King M; Bearman PS
    Soc Sci Med; 2017 Jan; 172():153-162. PubMed ID: 27856120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conflicts of interest in psychiatry: strategies to cultivate literacy in daily practice.
    Shimazawa R; Ikeda M
    Psychiatry Clin Neurosci; 2014 Jul; 68(7):489-97. PubMed ID: 24802771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.